arrow
D

Dickran Kazandjian

nih national heart lung & blood institute (nhlbi)
H指数:34
被引数:5,449

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma

无细胞DNA全基因组测序在评估高风险冒烟型多发性骨髓瘤微小残留病中的应用

2026-04-160
OAAI
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program

blastic plasmacytoid dendritic cell neoplasm (BPDCN):国际、多中心合作和全球登记项目

2025-12-210
OAAI
Selinexor, Venetoclax, and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)

Selinexor、Venetoclax和Dexamethasone在t(11;14)-阳性复发/难治性多发性骨髓瘤中的研究(SELVEDge研究)

BLOOD
IF23.1
2024-11-050
PRE
A Phase 2 Response-Adapted Study of Daratumumab, Carfilzomib, and Dexamethasone (DKd) in Patients with High-Risk Smoldering Multiple Myeloma

一项关于达鲁珠单抗、卡非佐米和地塞米松(DKd)在高危冒烟型多发性骨髓瘤患者中的2期适应性研究

BLOOD
IF23.1
2024-11-050
PRE
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
2023-11-098
PRE
Individualized risk stratification in newly diagnosed multiple myeloma
2023-04-040
PRE